Brief: Medinet receives patent for HSP105 from the US Patent and Trademark Office
05/09/2016 04:14
Sept 5 (Reuters) - Medinet Co Ltd 2370.T :
* Says the United States Patent and Trademark Office issued
the patent for HSP105
* HSP105 has been used for developing new technologies
such as Dendritic Cell (DC) therapy and cancer vaccines
Source text in Japanese: https://goo.gl/EWKxyc
Further company coverage: 2370.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))